On 23 June 2016 the UK population has voted for the UK’s exit from the European Union (EU). Although the referendum was an advisory referendum, it is expected that the UK will indeed decide to withdraw as a member of the EU and to start negotiations with the EU regarding its departure.
The full effects of Brexit in the field of competition enforcement will take some time to emerge. There will be an immediate risk of parallel investigations in both antitrust and merger fields, with an increased burden to businesses as well as some risk of inconsistent outcomes, although EU case-law is
The importance of bilateral trade between the UK and Belgium (British Chamber of Commerce in Belgium)
There is a strong and longstanding trade relationship between the UK and Belgium. It is without doubt this relationship is of great importance to both countries. UK exports to Belgium were worth 17,4 billion Euro in 2014, making Belgium the eighth largest export market for the UK. In 2015 Belgium
Following the UK’s referendum decision to exit from the EU and British Prime Minister Teresa May’s recent announcement that she would trigger the process to leave the EU by the end of March 2017, absent any express agreement to the contrary, the legal framework governing the relationship between the EU
The decision as to which model will be adopted by the UK and the EU post-Brexit will determine how the medical devices sector is truly affected. Initially, it seemed likely that the UK would remain within the European Economic Area (EEA), and the effects would likely to have been minimal
For anyone working in the financial services industry one of the main consequences of Brexit is passporting. That this was so rarely referred to during the referendum debate is unfortunate, as the potential loss of passporting rights for UK banks and financial institutions represents one of the biggest potential fallouts
It appears from Theresa May’s recent announcement that the UK will trigger Article 50 of the Treaty on the Functioning of the European Union (TFEU) by March 2017. The speculation from commentators now suggests that it is going to be a “hard Brexit”.
It appears that Brexit has taken the UK political elite by surprise and that the Leave campaign does not have a single unified plan for leaving Europe, so the ramifications of Brexit are likely to be uncertain until at least until 2017 according to UK Prime Minister May. However, there are unlikely to
Amongst the many uncertainties thrown up by the Brexit vote on 23 June 2016, is the impact of the UK leaving the EU on the regulatory regime governing the granting of marketing authorisation (“MA”) applications for medicinal products, as well as, the implications for the CE marking system for medical
As the debate widens and the complexity of the challenges of Brexit emerges, it is becoming increasingly difficult to simplify the issues at the centre of the discussion. Much is being written and The Financial Times this week (w/c 19 September) had some interesting articles.